BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14963082)

  • 1. Recombinant factor VIIa for uncontrolled bleeding in 2 different cases of coagulopathy.
    Islam J; Azhar S; Alperin JB; Syed I
    J Am Board Fam Pract; 2003; 16(6):549-52. PubMed ID: 14963082
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of recombinant factor VIIa in liver diseases.
    Franchini M; Montagnana M; Targher G; Zaffanello M; Lippi G
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):341-8. PubMed ID: 18600080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of recombinant activated factor VIIa for 18 patients with severe bleeding].
    Liu ZL; Yang L; Liu MM; Bai O; Cui JW; Li PT; Li W
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):409-11. PubMed ID: 22781803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa.
    Mindikoglu AL; Anantharaju A; George M; Leone N; Bejna J; Van Thiel DH
    Hepatogastroenterology; 2003; 50(53):1697-9. PubMed ID: 14571820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIIa for correction of traumatic coagulopathy.
    Dutton RP; McCunn M; Hyder M; D'Angelo M; O'Connor J; Hess JR; Scalea TM
    J Trauma; 2004 Oct; 57(4):709-18; discussion 718-9. PubMed ID: 15514523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant factor VIIa: how safe is the stuff?
    Roberts HR
    Can J Anaesth; 2005 Jan; 52(1):8-11. PubMed ID: 15625249
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjunctive role for recombinant activated factor VII in the treatment of bleeding secondary to a factor V inhibitor.
    William BM
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):327-8. PubMed ID: 18469559
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of anti-fibrinolytics, rFVIIa and other pro-coagulants: prophylactic versus rescue?
    Shah NL; Caldwell SH; Berg CL
    Clin Liver Dis; 2009 Feb; 13(1):87-93. PubMed ID: 19150313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute intracranial hemorrhage in a cirrhotic controlled with recombinant factor VIIa.
    Mindikoglu AL; Anantharaju A; George M; Shah NN; Villanueva J; van Thiel DH
    Dig Dis Sci; 2003 Jun; 48(6):1130-5. PubMed ID: 12822875
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries.
    Schreiber MA; Holcomb JB; Hedner U; Brundage SI; Macaitis JM; Hoots K
    J Trauma; 2002 Aug; 53(2):252-7; discussion 257-9. PubMed ID: 12169930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose recombinant factor VIIa for trauma patients with coagulopathy.
    Stein DM; Dutton RP; Hess JR; Scalea TM
    Injury; 2008 Sep; 39(9):1054-61. PubMed ID: 18656871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
    Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant factor VIIa to correct coagulopathy in patients with traumatic brain injury presenting to outlying facilities before transfer to the regional trauma center.
    Brown CV; Sowery L; Curry E; Valadka AB; Glover CS; Grabarkewitz K; Green T; Hail S; Admire J
    Am Surg; 2012 Jan; 78(1):57-60. PubMed ID: 22273315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of recombinant-activated factor VII in bleeding trauma patients.
    Dutton RP; Conti BM
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):299-304. PubMed ID: 19295430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute coagulopathy after reperfusion of the liver graft in children correction with recombinant activated factor VII.
    Markiewicz M; Kalicinski P; Kaminski A; Laniewski P; Ismail H; Drewniak T; Szymczak M; Nachulewicz P
    Transplant Proc; 2003 Sep; 35(6):2318-9. PubMed ID: 14529927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation management in massive bleeding.
    Griffee MJ; Deloughery TG; Thorborg PA
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):263-8. PubMed ID: 20104172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and treatment of major blood loss.
    Mannucci PM; Levi M
    N Engl J Med; 2007 May; 356(22):2301-11. PubMed ID: 17538089
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of traumatic bleeding with recombinant factor VIIa.
    Kenet G; Walden R; Eldad A; Martinowitz U
    Lancet; 1999 Nov; 354(9193):1879. PubMed ID: 10584732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions.
    Mittal S; Watson HG
    Br J Haematol; 2006 May; 133(4):355-63. PubMed ID: 16643441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponsive to conventional therapy.
    Gowers CJ; Parr MJ
    Anaesth Intensive Care; 2005 Apr; 33(2):196-200. PubMed ID: 15960401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.